BFSG, LLC

Position in GILD — Gilead Sciences, Inc.

CIK 1706836 IRVINE, CA

Position in GILD

as of Jun 30, 2026 · filed Jul 20, 2026 Compact

Position Value

$117,622

-$3,490 QoQ

Shares Held

931

+7.1% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#1,978

of 2,266 holders

Holding Since

Mar 2020

16 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

BFSG, LLC holds $27,089,521 across 12 Drug Manufacturers - General names. GILD ranks #9 (0.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABBV	AbbVie Inc.	22,116	$5,565,270
2	JNJ	Johnson & Johnson	21,466	$5,451,720
3	AMGN	Amgen Inc	13,879	$5,025,863
4	MRK	Merck & Co., Inc.	35,943	$4,618,675
5	LLY	ELI LILLY & Co	3,326	$3,989,304
6	PFE	Pfizer Inc	50,722	$1,221,385
7	NVO	Novo Nordisk A S	12,243	$586,929
8	OGN	Organon & Co.	29,058	$393,445

16 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$117,622	931	+7.1%	Shares	Sole	2026-07-20
2026-03-31	$121,112	869	-9.0%	Shares	Sole	2026-04-29
2025-12-31	$117,216	955	+0.5%	Shares	Sole	2026-01-22
2025-09-30	$105,450	950	+1.0%	Shares	Sole	2025-10-29
2025-06-30	$104,328	941	-2.6%	Shares	Sole	2025-07-15
2025-03-31	$108,240	966	-64.3%	Shares	Sole	2025-04-18
2024-12-31	$250,137	2,708	-37.4%	Shares	Sole	2025-01-31
2024-09-30	$362,608	4,325	-6.0%	Shares	Sole	2024-10-16
2024-06-30	$315,606	4,600	+4.5%	Shares	Sole	2024-07-29
2024-03-31	$322,446	4,402	+0.6%	Shares	Sole	2024-04-23
2023-12-31	$354,418	4,375	-2.6%	Shares	Sole	2024-04-23
2023-09-30	$336,480	4,490	-31.7%	Shares	Sole	2023-10-20
2022-06-30	$406,586	6,578	+124.3%	Shares	Sole	2022-08-04
2021-09-30	$204,870	2,933	-92.3%	Shares	Sole	2021-11-03
2020-06-30	$2,920,180	37,954	-1.7%	Shares	Sole	2020-07-22
2020-03-31	$2,885,661	38,599	—	Shares	Sole	2020-04-27
No filing history on record for this holder in this stock.